06/10/2026
WHY THIS STUDY?
If you're raising a child with Autism Spectrum Disorder, you've likely spent countless hours researching.
Researching therapies.
Researching treatments.
Researching specialists.
Researching ways to help your child communicate, connect, learn, and thrive.
You may have even heard about stem cell therapies being offered in other countries and wondered:
"Could this help my child?"
While no treatment can promise results, research is how we continue to learn, explore, and advance care for children and adults with autism.
Greater Atlanta Integrative Pediatrics is currently recruiting participants for an IRB-approved clinical research study evaluating the safety and preliminary effects of:
✔ Umbilical cord blood-derived stem cells and exosomes (AdiaVita)
✔ Glutathione support
This study is designed for individuals age 3 and older with Autism Spectrum Disorder and aims to gather important information that may help advance future autism research.
If you are interested in learning more about this research opportunity, our team is available to answer your questions.
📞 Learn more: 404-751-3693
🔗 FDA Information: NCT07622316
https://clinicaltrials.gov/study/NCT07622316?term=NCT07622316&rank=1
This is a research study. The treatment is investigational and is not FDA-approved for Autism Spectrum Disorder. Participation is voluntary, and there is no guarantee of benefit.
Maia A. Gaither, MD
Principal Investigator
Amy Westmoreland, MSN, APRN, FNP-C, FNP-BC
Sub-Investigator
Greater Atlanta Integrative Pediatrics
1240 Upper Hembree Drive, Suite A
Roswell, GA 30076
Study ID: GAIP-ASD-2026
Approved by Beyond Bound IRB
The purpose of this research study is to evaluate the safety and gather preliminary information about the effects of the investigational treatment. Because this treatment is investigational, potential risks and side effects are not fully known."
For questions about your rights as a research participant, please contact BeyondBound IRB (contact information).